Gantz et al.[205] used the CRISPR/Cas9 system to integrate antiparasite effector genes against the P. falciparum ookinete proteins, such as single-chain antibodies m1C3 to target chitinase 1 and m2A10 to target CSP, to prevent malaria transmission. Here, DNAJC5 is linked to malaria.